Back to News
Market Impact: 0.65

Deutsche Konsum REIT Q3 2024/2025 slides: Restructuring plan advances amid declining FFO

DKGCBRE
Corporate EarningsCompany FundamentalsM&A & RestructuringHousing & Real EstateCredit & Bond MarketsCorporate Guidance & OutlookAnalyst EstimatesInvestor Sentiment & Positioning
Deutsche Konsum REIT Q3 2024/2025 slides: Restructuring plan advances amid declining FFO

Deutsche Konsum REIT-AG (DKG) reported challenging Q3 2024/2025 results, with rental income down 11% to €52.7 million and Funds From Operations (FFO) declining 59% to €9.9 million, resulting in a net loss of €32.6 million. Despite reducing financial debt by 13.5% to €475.4 million, the company saw increased debt costs and a deteriorated interest coverage ratio of 1.1x. DKG is actively implementing a comprehensive restructuring plan, including securing lender standstill agreements and preparing for an €86 million debt-to-equity swap, as its stock trades near a 52-week low, reflecting significant investor concern over its financial stability and turnaround prospects.

Analysis

Deutsche Konsum REIT-AG (DKG) is navigating a severe financial crisis, as detailed in its Q3 2024/2025 results. The company's operational performance has deteriorated significantly, with Funds From Operations (FFO) plummeting 59% to €9.9 million and rental income declining 11% to €52.7 million, driven by strategic asset sales. This resulted in a net loss of €32.6 million, a stark reversal from a €15.7 million profit in the prior-year period. The balance sheet shows extreme distress; despite a 13.5% reduction in total financial debt to €475.4 million, the cost of debt has risen to 5.25% and the Interest Coverage Ratio (ICR) has collapsed to a precarious 1.1x from 3.3x, indicating the company can barely service its interest payments from operations. Furthermore, portfolio health is weakening, with the vacancy rate increasing to 14.9% and the weighted average lease term (WALT) shortening to 4.3 years, while a CBRE revaluation wiped €47.2 million from property values, contributing to the EPRA NTA per share falling to €6.71 from €11.37. The company's survival is now contingent on a comprehensive restructuring plan, which includes standstill agreements with lenders, bridge financing, and a critical €86 million debt-to-equity swap. The stock is trading near its 52-week low, reflecting deep market skepticism, which stands in stark contrast to a Warburg Research target price of €4.70, underscoring the high-risk, binary nature of the investment case.